Trump's weight loss drug deal promises big savings
Digest more
1don MSN
This next-gen weight-loss drug offers a new hope — and a bonus Ozempic and Wegovy don’t have
Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up to 20.1 percent of their body weight on eloralintide.
This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Bone Loss? Key takeaways: Taking Ozempic® may cause some bone density loss, but
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a country that has been called the world’s diabetes capital.
Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their waistlines.
A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight into potential new addiction therapies
US Weekly on MSN
Brooks Nader Gets ‘Honest’ About Her GLP-1 Addiction for Weight Loss: ‘It’s a Crutch for Me’
Brooks Nader is opening up about her addiction to using GLP-1 medications for weight loss. “If I didn’t get a job, I would say to [my old agency], ‘Can we get feedback from the client?’” Nader, 28, recalled in an interview with Bustle published on Wednesday.
Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from U.S. pharma giant Pfizer. On Monday, Pfizer said it had filed a second lawsuit against Novo and Metsera, arguing that Novo's bid for the smaller company was anticompetitive.
Feedback